We develop, manufacture and market innovative hemostasis reagents.
As experts in the coagulation business, we provide highest quality as well as greatest competence, innovativeness, reliability and friendliness for our business partners.
The chromogenic BIOPHEN™ DTI offers important advantages over coagulometric assays in the quantitative determination of direct thrombin inhibitors.
>>> Mehr lesen
Our new CE marked CRYOcheckTM factor VIII inhibitor kit contains the components required for performing a modified Nijmegen-Bethesda assay.
For supporting Heparin induced thrombocytopenia (HIT) diagnosis
Chromogenic assay for measuring Factor IX acitivity now available with 2x1 mL per reagent
For removal of DOACs from plasma specimens
Reliably measuring Protein Z
Factor VIII:C and Factor IX concentration of approx. 2%
CE certified chromogenic assay for measuring Factor VIII:C activity
- vWF Antigen
- Free Protein S
Chromogenic method for in vitro quantitative determination of Factor XIII ACTIVITY in human citrated plasma.
DOAC-Remove® and new calibrator & control plasmas for Rivaroxaban, Apixaban, Dabigatran, Edoxaban and DOAC-Remove
Chromogenic test kits for two-stage determination of anti-IIa and anti-Xa activity of UFH and LMWH in plasma or in purified systems.
>>> Weitere News
>> more Downloads